Who Buys What in Healthcare? A Product-to-Buyer Guide for MedTech, Pharma & HealthTech

Knowing what you sell is only half the job. The other half is knowing who buys it, and in healthcare those are rarely the same person. The surgeon who uses an implant doesn't sign the contract. The radiologist who loves an AI tool can't approve its connection to the hospital network. The oncologist who prescribes a therapy doesn't decide whether it's on the formulary.

That's why targeting "hospitals," "healthcare providers" or even "medical directors" so often disappoints. Those labels describe where buyers work, not who they are. Every product category has its own mix of clinical, operational, financial, technology and procurement stakeholders, and each of them weighs your product against a different set of priorities.

This guide maps who buys what across MedTech, HealthTech, diagnostics, pharma and clinical research, and healthcare services. Use it as a starting point for defining your audience, then adjust it to the specific organizations you sell to.

Who is involved in buying what you sell?

The structure of healthcare has changed in ways that make this question harder than it used to be. Research from the Physicians Advocacy Institute and Avalere found that 77.6% of U.S. physicians are now employed by hospitals or corporate entities. When most physicians work inside larger organizations, purchases move through organizational processes: value analysis committees, IT review, supply chain contracts and capital budgets. A physician's enthusiasm still matters, but it's rarely enough on its own.

A useful way to think about any healthcare purchase is to separate four roles:

• Users work with the product every day and judge whether it helps.
• Champions feel the problem most and push for change internally. They're often department or service line leaders.
• Evaluators check whether the product is safe, compatible, compliant and worth adding. Think IT, biomedical engineering, value analysis or pharmacy and therapeutics.
• Approvers control the budget and the contract: finance, procurement and executives.

Sometimes one person plays two of these roles. In a small practice, the physician owner may be user, champion and approver all at once. In a large health system, each role may be a separate committee. Either way, if your outreach only reaches the users, you're relying on them to sell your product internally to everyone else, and most of them have neither the time nor the vocabulary to do it well.

The quick-reference map below shows how this plays out for a few common categories: who to start with, who else needs to be involved, which facilities to target and what to qualify on.

MedTech and medical devices: mapping products to buyers

MedTech purchases usually start with a clinical need, and the physician who feels it most is your natural starting point. But devices that go into patients or into the operating room almost always pass through value analysis, and capital equipment brings finance and biomedical engineering into the room as well.

A few patterns are worth calling out. For implants and other physician preference items, the surgeon's preference carries real weight, but supply chain and value analysis teams are under steady pressure to standardize vendors and reduce cost. Expect them to ask why your product deserves a place next to, or instead of, what's already on contract. For capital equipment such as surgical robotics or imaging, the decision shifts toward OR and service line leadership, finance and the capital committee, and the timeline follows the hospital's budget cycle. We go deeper on that in how hospital type shapes surgical robotics sales.

The practical takeaway: for MedTech, the addressable market isn't just the clinicians who would use the device. It's every organization, department and stakeholder connected to the clinical and purchasing decision.

HealthTech: who buys healthcare technology

Healthcare software sits where clinical workflows, IT infrastructure and business operations meet, which is why HealthTech buying groups are often the widest of all. A clinical tool needs clinical champions, but it also needs IT to integrate and secure it, informatics to fit it into the workflow, and often an AI or data governance group to approve it.

Two roles deserve special attention. The CMIO or clinical informatics lead often acts as the bridge between physicians and IT. They can translate clinical value into technical requirements, and technical constraints back into language clinicians accept. The CISO, meanwhile, can stop almost any connected product late in the process if security questions haven't been answered. Bringing both into the conversation early tends to shorten deals noticeably.

It also helps to know what an organization already runs. An ambient AI tool that integrates well with one EHR may be a non-starter on another. Technology intelligence lets you qualify accounts on compatibility before you spend time on them, as we explain in why a health system's technology stack should shape your sales strategy.

Diagnostics and clinical equipment: where clinical and operational needs meet

Diagnostic and clinical equipment sits at the intersection of patient care, technical infrastructure, capital investment and day-to-day operations. The department that uses the equipment usually identifies the need, but finance, procurement, biomedical engineering and IT often have just as much say in what gets bought.

Laboratory and imaging purchases are a good example of why the "user" view falls short. A lab director may be the obvious contact for a new analyzer, but reagent contracts, service agreements, LIS integration and test menu decisions pull in procurement, IT and pathology. Imaging AI software adds data governance and IT security on top of radiology. And for sterilization equipment, infection prevention often has as much influence as the sterile processing team that operates it.

For these categories, the buying group stretches well beyond clinical users to the teams responsible for technology, capital and operational risk.

Pharma, biotech and clinical research: the stakeholder landscape

Pharma and biotech don't "sell" to hospitals in the same way device companies do, but the principle holds. Prescribers decide what to use for an individual patient, while pharmacy, formulary committees and market access stakeholders shape what's available and affordable. In clinical research, the people running trials, recruiting patients and managing sites each influence which partners and technologies get chosen.

The audience varies a lot by the type of therapy or service. A specialty or oncology therapy needs the prescribing specialists, but also the oncology pharmacists and pharmacy and therapeutics committee members who decide formulary status. Rare disease therapies depend heavily on referral networks and centers of excellence, since patients often pass through several specialists before reaching the right one. Research services and trial technology, meanwhile, are bought by research leadership with input from principal investigators and site staff who'll use them.

If your audience includes key opinion leaders, it's worth looking beyond publication counts. Our piece on how pharma identifies clinical influencers explains why.

Healthcare services and infrastructure: the buyers behind operational decisions

Services and infrastructure keep healthcare organizations running, so their buyers sit mostly on the operational, financial and administrative side. Clinical staff may feel the effects, sometimes very directly in the case of staffing, but the purchasing decision usually belongs elsewhere.

Healthcare staffing shows how the lines blur. Nursing leaders feel the shortage every shift and are usually the most motivated buyers, but HR, operations and procurement shape the contract, the rates and the vendor list. Revenue cycle services are similar: the revenue cycle director owns the problem, while the CFO owns the budget and the decision. A clear view of these roles helps you tell apart the teams who use a service from the ones responsible for bringing it in.

Five questions to identify the right buyers for your product

If your product isn't on any of these maps, or your situation is more specific, these five questions will get you most of the way. They're the same questions I'd ask about any healthcare purchase, and they work because they separate roles that a title list tends to blur together. As we've argued before, the single healthcare decision-maker is mostly a myth.

Here's how they apply to surgical robotics:

Run your own product through the same questions and you'll usually find two or three roles your current outreach doesn't reach. Those gaps are often where deals stall.

How buying groups change with organization size

The maps above describe a typical mid-sized or large hospital. Real organizations vary, and size changes the picture more than most teams account for.

• Large health systems often centralize decisions. Capital, IT and supply chain choices may be made at system level and applied across every facility, so reaching a single hospital's department head may not be enough. Look for system-level service line leaders, system CIOs and central value analysis teams.
• Community and independent hospitals have smaller buying groups and shorter paths to the decision. One executive may hold several roles, and personal relationships count for more.
• Physician practices and ambulatory centers often make decisions with a handful of people: physician owners, a practice administrator and perhaps an office manager. Per-case economics and day-to-day practicality usually carry the conversation.
• Academic medical centers add research and education to the mix. Department chairs, research leadership and teaching considerations can shape decisions as much as finance does.

There are about 6,100 hospitals in the U.S., and they don't all buy the same way. When you build an audience, map the buying group for each type of organization you target, not just the product.

Bottom line

For B2B healthcare marketers, a market is more than a list of hospitals, health systems or providers. Who you need to reach depends on what you sell and on everyone involved in using, championing, evaluating and approving it.

That makes buyer identification part of market definition, not something to sort out after the list is built. Start with the product, identify the roles and organizations connected to its purchase, and you'll end up with a smaller, sharper and far more useful view of your market.

The goal isn't to reach everyone in healthcare. It's to reach the organizations and people most relevant to your specific buying decision, and to give each of them a reason to say yes. If you'd like help building an audience around your actual buyers, talk to MedicalProspects.

Note: These maps describe common patterns. Buying groups vary by organization, and many purchases also involve value analysis, procurement, finance, clinical, technology and operational stakeholders alongside the primary buyer.

Frequently Asked Questions (FAQs)